home / stock / gkos / gkos quote
Last: | $99.48 |
---|---|
Change Percent: | -0.17% |
Open: | $100.28 |
Close: | $99.48 |
High: | $100.6 |
Low: | $98.53 |
Volume: | 288,682 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$99.48 | $100.28 | $99.48 | $100.6 | $98.53 | 288,682 | 04-26-2024 |
$100.11 | $99.07 | $100.11 | $100.26 | $97.18 | 286,328 | 04-25-2024 |
$100.93 | $101.24 | $100.93 | $103.66 | $100.75 | 520,810 | 04-24-2024 |
$101.1 | $99.49 | $101.1 | $101.24 | $98.31 | 351,098 | 04-23-2024 |
$98.95 | $97.14 | $98.95 | $99.83 | $96.365 | 363,654 | 04-22-2024 |
$96.5 | $95 | $96.5 | $98.7 | $94.16 | 697,810 | 04-19-2024 |
$95.13 | $96.68 | $95.13 | $97.285 | $94.14 | 381,950 | 04-18-2024 |
$96.89 | $96.99 | $96.89 | $98.635 | $96.15 | 288,738 | 04-17-2024 |
$96.95 | $95.98 | $96.95 | $98.36 | $95.795 | 430,348 | 04-16-2024 |
$96.84 | $98.99 | $96.84 | $99.48 | $95.79 | 336,568 | 04-15-2024 |
$98.23 | $98.42 | $98.23 | $99.33 | $97.09 | 353,673 | 04-12-2024 |
$99.26 | $100.46 | $99.26 | $100.97 | $98 | 374,204 | 04-11-2024 |
$99.71 | $99.14 | $99.71 | $101.04 | $98.84 | 417,919 | 04-10-2024 |
$101.31 | $100.17 | $101.31 | $102.33 | $99.69 | 394,898 | 04-09-2024 |
$100.63 | $97.36 | $100.63 | $102.32 | $97.01 | 1,304,887 | 04-08-2024 |
$96.77 | $93.81 | $96.77 | $97.77 | $93.18 | 545,742 | 04-05-2024 |
$94.12 | $94.95 | $94.12 | $96.78 | $94.09 | 482,806 | 04-04-2024 |
$94.31 | $89.94 | $94.31 | $97.75 | $89.94 | 913,124 | 04-03-2024 |
$89.48 | $91.54 | $89.48 | $92.22 | $88.16 | 822,310 | 04-02-2024 |
$93.1 | $94.55 | $93.1 | $94.96 | $91.51 | 352,308 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Shares of Glaukos Corporation (NYSE: GKOS) traded at a new 52-week high today and are currently trading at $102.98. So far today, approximately 56,347 shares have been exchanged, as compared to an average 30-day volume of 529.81k shares. Glaukos Corporation, an ophthalmic medical technology a...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has published its 2023 Sustainability Report. The report highlights the company...
2024-04-11 22:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...